Sarepta Therapeutics, Inc.
SRPT· Nasdaq
SRPTSarepta Therapeutics, Inc.
Filed May 7, 2015 · 10-Q · 37 days after period end · 0001193125-15-175829
| Metric | Q1 2015 | Q1 2014 | Q1 2013 | Q1 2012 |
|---|---|---|---|---|
| Net Income | -$61.56M | -$28.27M | -$42.08M | -$17.70M |
| EPS Diluted | -$1.49 | -$0.75 | -$1.32 | -$0.78 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sarepta Therapeutics, Inc. · CIK 873303 · Engraved from SEC EDGAR
ended Mar 31, 2015 · filed May 7, 2015 · 37 d after period end
